Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter Golgin B1 (GOLGB1) Antikörper

Dieses Human Monoklonal-Antikörper erkennt spezifisch in ICC. Er zeigt eine Reaktivität gegenüber Human und Maus und wurde in 2+ Publikationen erwähnt.
Produktnummer ABIN1169059

Kurzübersicht für Rekombinanter Golgin B1 (GOLGB1) Antikörper (ABIN1169059)

Target

Alle Golgin B1 (GOLGB1) Antikörper anzeigen
Golgin B1 (GOLGB1)

Antikörpertyp

Recombinant Antibody

Reaktivität

  • 33
  • 21
  • 20
  • 1
  • 1
  • 1
  • 1
  • 1
Human, Maus

Wirt

  • 28
  • 4
  • 2
  • 1
  • 1
Human

Klonalität

  • 29
  • 7
Monoklonal

Konjugat

  • 15
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Unkonjugiert

Applikation

  • 28
  • 15
  • 13
  • 13
  • 9
  • 6
  • 6
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
Immunocytochemistry (ICC)

Klon

TA10
  • Spezifität

    Recognizes human and mouse giantin.

    Kreuzreaktivität

    Human, Maus

    Aufreinigung

    Purified from HEK 293 cell culture supernatant.

    Reinheit

    >95 % (SDS-PAGE)

    Immunogen

    Human recombinant giantin.

    Isotyp

    IgG2
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Kommentare

    anti-Giantin, monoclonal antibody (recombinant) (TA10) is composed of human variable regions (VH and VL) (lambda-chain) of immunoglobulin fused to the human lgG2 Fc domain. anti-Giantin, monoclonal antibody (recombinant) (TA10) is an antibody developed by antibody phage display technology using a human naive antibody gene library. These libraries consist of scFv (single chain fragment variable) composed of VH (variable domain of the human immunoglobulin heavy chain) and VL (variable domain of the human immunoglobulin light chain) connected by a polypeptide linker. The antibody fragments are displayed on the surface of filamentous bacteriophage (M13). This scFv was selected by affinity selection on antigen in a process termed panning. Multiple rounds of panning are performed to enrich for antigen-specific scFv-phage. Monoclonal antibodies are subsequently identified by screening after each round of selection. The selected monoclonal scFv is cloned into an appropriate vector containing a Fc portion of interest and then produced in mammalian cells to generate an IgG like scFv-Fc fusion protein.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    Lot specific

    Buffer

    In PBS containing 10 % glycerol and 0.02 % sodium azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Short Term Storage: +4°C
    Long Term Storage: -20°C
    Stable for at least 1 month after receipt when stored at +4°C. Stable for at least 1 year after receipt when stored at -20°C.

    Haltbarkeit

    12 months
  • Vielemeyer, Nizak, Jimenez, Echard, Goud, Camonis, Rain, Perez: "Characterization of single chain antibody targets through yeast two hybrid." in: BMC biotechnology, Vol. 10, pp. 59, (2010) (PubMed).

    Nizak, Martin-Lluesma, Moutel, Roux, Kreis, Goud, Perez: "Recombinant antibodies against subcellular fractions used to track endogenous Golgi protein dynamics in vivo." in: Traffic (Copenhagen, Denmark), Vol. 4, Issue 11, pp. 739-53, (2003) (PubMed).

  • Target

    Golgin B1 (GOLGB1)

    Andere Bezeichnung

    Giantin

    Hintergrund

    Giantin, the largest Golgi membrane protein, is C-terminally anchored to cis- and medial-Golgi membranes and forms a long ~250nm coiled-coil rod that directly interacts with microtubules in a cell-cycle regulated way. It is an excellent marker for mammalian golgi complex. It is also an antigen in chronic rheumatoid arthritis and in the autoimmune disease Sjoegren syndrome.

    UniProt

    Q14789

    Pathways

    SARS-CoV-2 Protein Interaktom
Sie sind hier:
Chat with us!